GKIM
ASTH icon

GW&K Investment Management’s Astrana Health ASTH Stock Holding History

GW&K Investment Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,517
Closed -$1.96M – 853
2022
Q1 		$1.96M Sell
40,517
-779
-2% -$40.2K 0.02% 310
2021
Q4 		$3.03M Sell
41,296
-48,040
-54% -$3.95M 0.03% 299
2021
Q3 		$8.13M Sell
89,336
-87,114
-49% -$7.41M 0.07% 225
2021
Q2 		$11.1M Buy
176,450
+35,701
+25% +$1.32M 0.1% 217
2021
Q1 		$3.81M Buy
+140,749
New +$3.39M 0.04% 303

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GW&K Investment Management's ASTH Position: Q2 2022 in Review

GW&K Investment Management sold out of Astrana Health (ASTH) in Q2 2022, closing a stake of 40,517 shares — an estimated $1.96M sold.

GW&K Investment Management first reported a position in ASTH in Q1 2021 and held it in 5 quarters. The position peaked at $11.1M in Q2 2021. 134 funds tracked by Wall St. Rank hold ASTH as of Q2 2022.

  • GW&K Investment Management reported no remaining Astrana Health position as of Q2 2022 after selling out during the quarter.
  • GW&K Investment Management sold 40,517 Astrana Health shares in Q2 2022, an estimated $1.96M.
  • GW&K Investment Management first reported a position in Astrana Health in Q1 2021 and held it in 5 quarters.
  • GW&K Investment Management's Astrana Health position peaked at $11.1M in Q2 2021.
  • 134 funds tracked by Wall St. Rank held Astrana Health as of Q2 2022.

Based on GW&K Investment Management's 13F filing for Q2 2022, filed 9 Aug 2022.